Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Other Non-Current Liabilities (2022 - 2026)

Axsome Therapeutics' Other Non-Current Liabilities history spans 5 years, with the latest figure at $73.7 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 18.61% to $73.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $73.7 million, a 18.61% decrease, with the full-year FY2025 number at $77.5 million, down 15.42% from a year prior.
  • Other Non-Current Liabilities hit $73.7 million in Q1 2026 for Axsome Therapeutics, down from $77.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for AXSM hit a ceiling of $91.7 million in Q4 2024 and a floor of $27.4 million in Q3 2022.
  • Historically, Other Non-Current Liabilities has averaged $61.3 million across 5 years, with a median of $71.6 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 163.01% in 2024 and later dropped 18.61% in 2026.
  • Tracing AXSM's Other Non-Current Liabilities over 5 years: stood at $31.1 million in 2022, then surged by 135.69% to $73.3 million in 2023, then increased by 25.08% to $91.7 million in 2024, then dropped by 15.42% to $77.5 million in 2025, then dropped by 4.91% to $73.7 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for AXSM at $73.7 million in Q1 2026, $77.5 million in Q4 2025, and $89.9 million in Q3 2025.